GO:0005515 | protein binding | 20.43% (19/93) | 2.01 | 0.0 | 5.4e-05 |
GO:0009987 | cellular process | 25.81% (24/93) | 1.54 | 1e-06 | 0.00021 |
GO:0006807 | nitrogen compound metabolic process | 21.51% (20/93) | 1.6 | 6e-06 | 0.000283 |
GO:0004484 | mRNA guanylyltransferase activity | 2.15% (2/93) | 8.8 | 5e-06 | 0.000305 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.15% (2/93) | 8.8 | 5e-06 | 0.000305 |
GO:0043170 | macromolecule metabolic process | 20.43% (19/93) | 1.66 | 6e-06 | 0.000327 |
GO:0016779 | nucleotidyltransferase activity | 5.38% (5/93) | 4.48 | 3e-06 | 0.000328 |
GO:0008192 | RNA guanylyltransferase activity | 2.15% (2/93) | 8.22 | 1.5e-05 | 0.000415 |
GO:0036260 | RNA capping | 2.15% (2/93) | 8.22 | 1.5e-05 | 0.000415 |
GO:0070568 | guanylyltransferase activity | 2.15% (2/93) | 8.22 | 1.5e-05 | 0.000415 |
GO:0009452 | 7-methylguanosine RNA capping | 2.15% (2/93) | 8.22 | 1.5e-05 | 0.000415 |
GO:0044237 | cellular metabolic process | 21.51% (20/93) | 1.51 | 1.7e-05 | 0.000444 |
GO:0016740 | transferase activity | 18.28% (17/93) | 1.6 | 3.9e-05 | 0.000919 |
GO:0005488 | binding | 33.33% (31/93) | 1.03 | 4.5e-05 | 0.00099 |
GO:0043015 | gamma-tubulin binding | 2.15% (2/93) | 7.22 | 7.4e-05 | 0.001516 |
GO:0090304 | nucleic acid metabolic process | 7.53% (7/93) | 2.71 | 0.000101 | 0.001562 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 12.9% (12/93) | 1.91 | 8.1e-05 | 0.001565 |
GO:0036211 | protein modification process | 12.9% (12/93) | 1.88 | 0.0001 | 0.001613 |
GO:0006464 | cellular protein modification process | 12.9% (12/93) | 1.88 | 0.0001 | 0.001613 |
GO:0006139 | nucleobase-containing compound metabolic process | 8.6% (8/93) | 2.5 | 9e-05 | 0.001637 |
GO:0044238 | primary metabolic process | 21.51% (20/93) | 1.31 | 0.000114 | 0.001667 |
GO:0043412 | macromolecule modification | 12.9% (12/93) | 1.85 | 0.000123 | 0.001718 |
GO:0004652 | polynucleotide adenylyltransferase activity | 2.15% (2/93) | 6.8 | 0.000137 | 0.00184 |
GO:0071704 | organic substance metabolic process | 21.51% (20/93) | 1.25 | 0.000199 | 0.002559 |
GO:0140097 | catalytic activity, acting on DNA | 3.23% (3/93) | 4.66 | 0.000234 | 0.00267 |
GO:0006725 | cellular aromatic compound metabolic process | 8.6% (8/93) | 2.3 | 0.00023 | 0.002723 |
GO:0046483 | heterocycle metabolic process | 8.6% (8/93) | 2.31 | 0.000222 | 0.002729 |
GO:0043631 | RNA polyadenylation | 2.15% (2/93) | 6.34 | 0.000269 | 0.002956 |
GO:1901360 | organic cyclic compound metabolic process | 8.6% (8/93) | 2.26 | 0.000278 | 0.002956 |
GO:0044260 | cellular macromolecule metabolic process | 15.05% (14/93) | 1.53 | 0.000319 | 0.003279 |
GO:0043413 | macromolecule glycosylation | 3.23% (3/93) | 4.44 | 0.000372 | 0.003584 |
GO:0006486 | protein glycosylation | 3.23% (3/93) | 4.44 | 0.000372 | 0.003584 |
GO:0003674 | molecular_function | 45.16% (42/93) | 0.67 | 0.000388 | 0.003622 |
GO:0070085 | glycosylation | 3.23% (3/93) | 4.32 | 0.000468 | 0.004239 |
GO:0070566 | adenylyltransferase activity | 2.15% (2/93) | 5.9 | 0.00051 | 0.004488 |
GO:0044267 | cellular protein metabolic process | 12.9% (12/93) | 1.6 | 0.000594 | 0.005083 |
GO:0033043 | regulation of organelle organization | 2.15% (2/93) | 5.72 | 0.000659 | 0.005483 |
GO:0019538 | protein metabolic process | 13.98% (13/93) | 1.47 | 0.000777 | 0.006301 |
GO:0022402 | cell cycle process | 2.15% (2/93) | 5.56 | 0.000826 | 0.006521 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 2.15% (2/93) | 5.48 | 0.000916 | 0.007054 |
GO:0051128 | regulation of cellular component organization | 2.15% (2/93) | 5.41 | 0.001011 | 0.007595 |
GO:0004721 | phosphoprotein phosphatase activity | 2.15% (2/93) | 5.28 | 0.001215 | 0.0087 |
GO:0016070 | RNA metabolic process | 5.38% (5/93) | 2.67 | 0.001195 | 0.008764 |
GO:0051985 | negative regulation of chromosome segregation | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0033046 | negative regulation of sister chromatid segregation | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0010948 | negative regulation of cell cycle process | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0048365 | Rac GTPase binding | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0031577 | spindle checkpoint | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0045839 | negative regulation of mitotic nuclear division | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0045930 | negative regulation of mitotic cell cycle | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0051784 | negative regulation of nuclear division | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0007093 | mitotic cell cycle checkpoint | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:1905819 | negative regulation of chromosome separation | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0071173 | spindle assembly checkpoint | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0071174 | mitotic spindle checkpoint | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:1901988 | negative regulation of cell cycle phase transition | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1.08% (1/93) | 8.8 | 0.002237 | 0.010765 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.6% (8/93) | 1.77 | 0.002434 | 0.011534 |
GO:0005524 | ATP binding | 10.75% (10/93) | 1.53 | 0.002473 | 0.011539 |
GO:0016311 | dephosphorylation | 2.15% (2/93) | 5.0 | 0.001801 | 0.01261 |
GO:0016409 | palmitoyltransferase activity | 2.15% (2/93) | 4.68 | 0.002807 | 0.012904 |
GO:0031267 | small GTPase binding | 2.15% (2/93) | 4.63 | 0.002968 | 0.013248 |
GO:0017016 | Ras GTPase binding | 2.15% (2/93) | 4.63 | 0.002968 | 0.013248 |
GO:0006886 | intracellular protein transport | 3.23% (3/93) | 3.38 | 0.003089 | 0.013593 |
GO:0140096 | catalytic activity, acting on a protein | 11.83% (11/93) | 1.47 | 0.002073 | 0.014189 |
GO:1901564 | organonitrogen compound metabolic process | 13.98% (13/93) | 1.22 | 0.003677 | 0.015512 |
GO:0008144 | drug binding | 10.75% (10/93) | 1.45 | 0.003601 | 0.01562 |
GO:0006397 | mRNA processing | 2.15% (2/93) | 4.48 | 0.003653 | 0.015627 |
GO:0032559 | adenyl ribonucleotide binding | 10.75% (10/93) | 1.43 | 0.003955 | 0.016463 |
GO:0030554 | adenyl nucleotide binding | 10.75% (10/93) | 1.43 | 0.004057 | 0.016659 |
GO:0008150 | biological_process | 30.11% (28/93) | 0.71 | 0.004176 | 0.016925 |
GO:0006396 | RNA processing | 3.23% (3/93) | 3.21 | 0.004287 | 0.017149 |
GO:0006796 | phosphate-containing compound metabolic process | 9.68% (9/93) | 1.5 | 0.00457 | 0.017376 |
GO:0006793 | phosphorus metabolic process | 9.68% (9/93) | 1.5 | 0.00457 | 0.017376 |
GO:0051020 | GTPase binding | 2.15% (2/93) | 4.34 | 0.004405 | 0.017394 |
GO:2001251 | negative regulation of chromosome organization | 1.08% (1/93) | 7.8 | 0.004469 | 0.017423 |
GO:0016791 | phosphatase activity | 2.15% (2/93) | 4.28 | 0.004805 | 0.01805 |
GO:0051649 | establishment of localization in cell | 3.23% (3/93) | 3.11 | 0.00516 | 0.018921 |
GO:0046907 | intracellular transport | 3.23% (3/93) | 3.11 | 0.00516 | 0.018921 |
GO:0030117 | membrane coat | 2.15% (2/93) | 4.19 | 0.005436 | 0.019699 |
GO:0016071 | mRNA metabolic process | 2.15% (2/93) | 4.16 | 0.005655 | 0.020252 |
GO:0035639 | purine ribonucleoside triphosphate binding | 10.75% (10/93) | 1.35 | 0.005932 | 0.021001 |
GO:0008152 | metabolic process | 21.51% (20/93) | 0.85 | 0.006104 | 0.021364 |
GO:0000278 | mitotic cell cycle | 1.08% (1/93) | 7.22 | 0.006696 | 0.022416 |
GO:0051129 | negative regulation of cellular component organization | 1.08% (1/93) | 7.22 | 0.006696 | 0.022416 |
GO:0010639 | negative regulation of organelle organization | 1.08% (1/93) | 7.22 | 0.006696 | 0.022416 |
GO:0070652 | HAUS complex | 1.08% (1/93) | 7.22 | 0.006696 | 0.022416 |
GO:0051641 | cellular localization | 3.23% (3/93) | 2.96 | 0.006875 | 0.022528 |
GO:0006996 | organelle organization | 2.15% (2/93) | 4.02 | 0.006805 | 0.022538 |
GO:0042886 | amide transport | 3.23% (3/93) | 2.92 | 0.007437 | 0.023613 |
GO:0015833 | peptide transport | 3.23% (3/93) | 2.92 | 0.007437 | 0.023613 |
GO:0015031 | protein transport | 3.23% (3/93) | 2.92 | 0.007437 | 0.023613 |
GO:0033036 | macromolecule localization | 3.23% (3/93) | 2.88 | 0.008024 | 0.024714 |
GO:0008104 | protein localization | 3.23% (3/93) | 2.88 | 0.008024 | 0.024714 |
GO:0007051 | spindle organization | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0007049 | cell cycle | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0004659 | prenyltransferase activity | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0008318 | protein prenyltransferase activity | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0097354 | prenylation | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0004576 | oligosaccharyl transferase activity | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0051225 | spindle assembly | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0018342 | protein prenylation | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0000075 | cell cycle checkpoint | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0000226 | microtubule cytoskeleton organization | 1.08% (1/93) | 6.8 | 0.008918 | 0.024745 |
GO:0045184 | establishment of protein localization | 3.23% (3/93) | 2.89 | 0.007905 | 0.024843 |
GO:0019899 | enzyme binding | 2.15% (2/93) | 3.8 | 0.009119 | 0.024856 |
GO:0032553 | ribonucleotide binding | 10.75% (10/93) | 1.25 | 0.009246 | 0.02498 |
GO:0017076 | purine nucleotide binding | 10.75% (10/93) | 1.26 | 0.009116 | 0.02507 |
GO:0097367 | carbohydrate derivative binding | 10.75% (10/93) | 1.24 | 0.009609 | 0.025736 |
GO:0010965 | regulation of mitotic sister chromatid separation | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0007088 | regulation of mitotic nuclear division | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0051783 | regulation of nuclear division | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:1905818 | regulation of chromosome separation | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:1901987 | regulation of cell cycle phase transition | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0061505 | DNA topoisomerase II activity | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0000775 | chromosome, centromeric region | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0033045 | regulation of sister chromatid segregation | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0051983 | regulation of chromosome segregation | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:1903047 | mitotic cell cycle process | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 1.08% (1/93) | 6.48 | 0.011135 | 0.026381 |
GO:0032555 | purine ribonucleotide binding | 10.75% (10/93) | 1.26 | 0.008799 | 0.026832 |
GO:0042578 | phosphoric ester hydrolase activity | 2.15% (2/93) | 3.63 | 0.011429 | 0.026872 |
GO:0071705 | nitrogen compound transport | 3.23% (3/93) | 2.67 | 0.011966 | 0.027919 |
GO:0098687 | chromosomal region | 1.08% (1/93) | 6.22 | 0.013347 | 0.029364 |
GO:0033044 | regulation of chromosome organization | 1.08% (1/93) | 6.22 | 0.013347 | 0.029364 |
GO:0007346 | regulation of mitotic cell cycle | 1.08% (1/93) | 6.22 | 0.013347 | 0.029364 |
GO:0010564 | regulation of cell cycle process | 1.08% (1/93) | 6.22 | 0.013347 | 0.029364 |
GO:0010498 | proteasomal protein catabolic process | 1.08% (1/93) | 6.22 | 0.013347 | 0.029364 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.08% (1/93) | 6.22 | 0.013347 | 0.029364 |
GO:0008094 | DNA-dependent ATPase activity | 1.08% (1/93) | 6.22 | 0.013347 | 0.029364 |
GO:0070925 | organelle assembly | 1.08% (1/93) | 6.22 | 0.013347 | 0.029364 |
GO:0071702 | organic substance transport | 3.23% (3/93) | 2.59 | 0.013704 | 0.029935 |
GO:0003824 | catalytic activity | 23.66% (22/93) | 0.69 | 0.014747 | 0.031986 |
GO:0015631 | tubulin binding | 2.15% (2/93) | 3.43 | 0.014977 | 0.032259 |
GO:0016043 | cellular component organization | 3.23% (3/93) | 2.52 | 0.015756 | 0.033701 |
GO:1901265 | nucleoside phosphate binding | 10.75% (10/93) | 1.13 | 0.016083 | 0.033929 |
GO:0000166 | nucleotide binding | 10.75% (10/93) | 1.13 | 0.016083 | 0.033929 |
GO:0006468 | protein phosphorylation | 7.53% (7/93) | 1.41 | 0.016541 | 0.034657 |
GO:0004672 | protein kinase activity | 7.53% (7/93) | 1.39 | 0.01782 | 0.036348 |
GO:0032296 | double-stranded RNA-specific ribonuclease activity | 1.08% (1/93) | 5.8 | 0.017757 | 0.036461 |
GO:0030163 | protein catabolic process | 1.08% (1/93) | 5.8 | 0.017757 | 0.036461 |
GO:0004525 | ribonuclease III activity | 1.08% (1/93) | 5.8 | 0.017757 | 0.036461 |
GO:0043168 | anion binding | 10.75% (10/93) | 1.08 | 0.019498 | 0.039508 |
GO:0006265 | DNA topological change | 1.08% (1/93) | 5.63 | 0.019955 | 0.039652 |
GO:0003916 | DNA topoisomerase activity | 1.08% (1/93) | 5.63 | 0.019955 | 0.039652 |
GO:0016310 | phosphorylation | 7.53% (7/93) | 1.36 | 0.019868 | 0.039995 |
GO:0036094 | small molecule binding | 10.75% (10/93) | 1.07 | 0.021088 | 0.041371 |
GO:0005634 | nucleus | 3.23% (3/93) | 2.36 | 0.020974 | 0.041411 |
GO:0071840 | cellular component organization or biogenesis | 3.23% (3/93) | 2.34 | 0.021606 | 0.042118 |
GO:0006289 | nucleotide-excision repair | 1.08% (1/93) | 5.48 | 0.022147 | 0.042633 |
GO:0071103 | DNA conformation change | 1.08% (1/93) | 5.48 | 0.022147 | 0.042633 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 7.53% (7/93) | 1.3 | 0.024359 | 0.042871 |
GO:0032535 | regulation of cellular component size | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0008064 | regulation of actin polymerization or depolymerization | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0090066 | regulation of anatomical structure size | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0110053 | regulation of actin filament organization | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:1902903 | regulation of supramolecular fiber organization | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0003684 | damaged DNA binding | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0043254 | regulation of protein complex assembly | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0005875 | microtubule associated complex | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0051493 | regulation of cytoskeleton organization | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0030832 | regulation of actin filament length | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0030833 | regulation of actin filament polymerization | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0032271 | regulation of protein polymerization | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0032970 | regulation of actin filament-based process | 1.08% (1/93) | 5.34 | 0.024335 | 0.043076 |
GO:0016301 | kinase activity | 7.53% (7/93) | 1.28 | 0.025465 | 0.044564 |
GO:0044087 | regulation of cellular component biogenesis | 1.08% (1/93) | 5.22 | 0.026518 | 0.045375 |
GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters | 1.08% (1/93) | 5.22 | 0.026518 | 0.045375 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.08% (1/93) | 5.22 | 0.026518 | 0.045375 |
GO:0045786 | negative regulation of cell cycle | 1.08% (1/93) | 5.22 | 0.026518 | 0.045375 |
GO:0003887 | DNA-directed DNA polymerase activity | 1.08% (1/93) | 5.1 | 0.028696 | 0.048831 |
GO:0043231 | intracellular membrane-bounded organelle | 3.23% (3/93) | 2.17 | 0.029236 | 0.049205 |
GO:0043227 | membrane-bounded organelle | 3.23% (3/93) | 2.17 | 0.029236 | 0.049205 |